Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

PFE 29.40 +0.24 (0.82%)
price chart
Pfizer Inc Declares Third-Quarter 2012 Dividend
Reuters Key Development - Jun 28, 2012
Nestle SA In Talks For EUR7 Billion Acquisition Loan To Help Fund $11.85 Billion Takeover Of Pfizer, Inc.'s Nutrition-Reuters
Reuters Key Development - Jun 28, 2012
Breckenridge and Alembic Pharmaceuticals Limited Announce Paragraph IV ANDA Litigation with Pfizer Inc on Desvenlafaxine Tablets (Pristiq)
Reuters Key Development - Jun 28, 2012
Bristol-Myers Squibb Co And Pfizer, Inc. Receives Complete Response Letter From U.S. Food And Drug Administration For ELIQUIS (apixaban)
Reuters Key Development - Jun 25, 2012
European Medicines Agency Committee For Medicinal Products For Human Use Adopts Opinion On Pfizer Inc And Protalix BioTherapeutics, Inc.'s Taliglucerase Alfa Marketing Authorization Application
Reuters Key Development - Jun 22, 2012
Pfizer Inc Announces FDA Approved Lyrica
Reuters Key Development - Jun 21, 2012
Pfizer Inc Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer
Reuters Key Development - Jun 19, 2012
FDA Seeks More Data On Pfizer Inc Rare Disease Drug-Reuters
Reuters Key Development - Jun 18, 2012
Takeda Pharmaceutical Company Limited To Stop Selling 13 Pfizer, Inc. Drugs In Japan-Reuters
Reuters Key Development - Jun 18, 2012
CVS Caremark Corporation, Rite Aid Corporation Sue Pfizer Inc And Teva Pharmaceutical Industries Ltd Over Depression Drug-Reuters
Reuters Key Development - Jun 12, 2012

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
To see all exchange delays, please see disclaimer.

©2013 Google - Google Home - Blog - Help - Report a Problem - Privacy Policy - Terms of Service